Navigation Links
Glivec in Medical News

Researchers unveil vital key to cancer

...normous importance to the pharmaceutical industry. Over 100 kinase inhibitors are currently in clinical trials, and the revolutionary kinase inhibitor glivec was approved for treating Leukaemia in the UK in 2001. Mps1 is particularly important as it controls a 'checkpoint' that cells use to encourage acc...

Patents: Appellate Board Becomes Functional

...Novartis AG went before the High Court seeking reversal of the Chennai-based Controller’s rejection of its patent application for its anti-cancer drug glivec in January 2006. As per the Indian patent laws, appeals against rejection of a patent application should first go before the Appellate Board se...

Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board

...tion of its patent// plea for the anti-cancer drug glivec to the Intellectual Property Appellate Board. ...atent Office, who had rejected its application for glivec patent. A spokesperson of the Novartis has already...has considerably better efficacy. Novartis’s glivec was a new form of an older molecule that it first ...

Ambiguity In Patent Laws May Defer New Drug Launches

... patented products. But this in any way will not affect the distribution of glivec here. According to him, Novartis through its foundation has been distributing glivec to needy patients to the tune of 1270 crore in India. Trade analysts op...

To Patent or Not-A Question of Life

...he quality of life for an AIDS patient; a nightmare or a manageable crisis. Novartis is backing its right to patent a modified version of its drug glivec produced in India, used to treat leukemia. If it wins its case this will mean the cost of the drug shooting to almost ten times its present value and ...

Glivec Enhances Survival Rates In Leukemia

...rug approvals in the UK had only wanted to approve glivec for advanced cases, but the drug has not proved it...o a defect in the production of white blood cells. glivec targets only the affected molecules and leaves the...ould have believed I would be standing here today. glivec helped save my life and I am grateful that I can p...

Leukemia Gets A New Drug

...say that Sorafenib (Nexavar) is a better drug than glivec for Chronic Eosinophilic Leukemia //(CEL). They said that although glivec has a good track record, it is known to cause resi...ts use proteins that inhibit the tyrosine kinases. glivec is such an inhibitor and is effective against CEL ...

Glivec the hot cancer drug from Novartis

...drugs killsoff healthy cells along with sick ones, glivec interfere with the proteins that cause tumors to grow. glivec also is used to treat other rare types of cancer s...the end of this year. Although an annual course of glivec can cost as much as $25,000, demand for the drug t...

Glivec - New Hope For CMC Patients

...ology in San Francisco, on Saturday Evening. The researchers added up to 30% patients have no traces of the disease after being treated with Glivec. glivec comes as an alternative to painful bone marrow transplants and - interferon, a more toxic injectable treatment. ...
Glivec in Medical Technology

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... Investors only: Richard Jarvis Novartis Corporation P: +1 212 830 2433 e-mail: investor.relations@novartis.com (#) Known as glivec (imatinib) outside the US, Canada and Israel. (*) Updated data from all abstracts may be presented at the ASCO annual meeting ...

Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery

... demonstrates that 98% of patients receiving 400mg glivec daily for a year after surgery to remove their GIS...an the initial tumours.(3,4,7) The availability of glivec for this patient population addresses a previously...ge recurring GISTs. We hope that the future use of glivec in the adjuvant setting will help to reduce the ri...

Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)

...ople with CML can be treated in the long term with glivec (imatinib) but a small amount of people, estimated...develop resistance to or are intolerant of Glivec. glivec signified a revolution in the way we think about t... Japan for the treatment of all phases of Ph+ CML. glivec is also approved in the EU, US and other countries...

Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study

... * glivec found to dramatically reduce the risk of cancer re...* Global regulatory submissions planned for use of glivec as adjuvant therapy in GIST patients following surgery to remove primary tumor * glivec already approved as effective therapy for patients...
Glivec in Medical Dictionary

Cml

... Glivec® (imatinib) is the standard of care for Philadelphia chromosome-positive CML (Ph+ CML ). Get information for diagnosing and prescribing glivec as a first ... Chronic myelocytic leukemia ( CML ) may affect people of any age and of either sex ... The diagnosis of CML is suspected ba...
Glivec in Biological Technology

Modifying an anti-cancer drug makes it more specific

... Imatinib (marketed as Gleevec in the US and glivec in Europe and Australia) is used to treat various cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It ca...

JCI table of contents: Dec. 3, 2007

...org/article.php?id=34251 EDITOR'S PICK: Modifying an anticancer drug makes it more specific Imatinib (marketed as Gleevec in the US and glivec in Europe and Australia) is used to treat various cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It ca...
Other Tags
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 ... have reached a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... developed gynecomastia due to his use of the ... had been selected for the third bellwether trial ... mass tort litigation underway in Pennsylvania’s Philadelphia Court ...
(Date:5/29/2015)... World Patent Marketing, a vertically integrated ... has signed a 10 year licensing agreement for Live ... let people learn about any topic and get answers ... is an exciting day for World Patent Marketing and ... CEO and Creative Director of World Patent Marketing, "This ...
(Date:5/29/2015)... 29, 2015 The print component of ... circulation of approximately 250,000 and an estimated readership of ... vast social media strategy, and across a network of ... digital version of the campaign, click here. ... publication. Inside, the actress, model and producer details her ...
(Date:5/29/2015)... 2015 The campaign focuses on the ... number of specific concerns within, including the importance of ... health in the workplace. We are encouraged to re-think ... also brings special focus to people living with bipolar ... and seek help from healthcare professionals and their overall ...
(Date:5/29/2015)... La Mirada, Ca (PRWEB) May 29, 2015 ... services, including pain consultations with specialists, physical therapy, ... who are experiencing mid back and/or lower back ... offering lumbar epidural injections for herniated discs, disc ... spine pain . , Healthpointe’s team of ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ) ... Recognition Market by Solution, by Software, by Hardware, ... report to their offering. The ... become more efficient and cost effective. This has ... from the commercial sector. The development of 3D ...
(Date:5/28/2015)... 2015 Industry analyst firm n-tech Research ... titled "Markets for Self-Healing Materials: 2015-2022." According to the ... vascular systems, biomaterials, relevant shape memory materials and ... billion by 2020. The report is ... smart materials. Other recent n-tech reports have included studies ...
(Date:5/27/2015)... , May 27, 2015   Codonics ... safety systems and image documentation solutions and ... comprehensive, technologically-advanced automation solutions, is pleased to ... The Codonics® Safe Label System® (SLS), an ... conjunction with the Omnicell Anesthesia Workstation, helps ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4
Other Contents